Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

The Pill prevents pregnancy -- and maybe ovarian cancer, too, a new study suggests.Women who’ve ever used the contra ...

Human papillomavirus (HPV) remains one of the most prevalent viral infections globally, affecting millions across ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or ...

The resources provided by Olivia include an interactive ovarian cancer pathway and guidance on diagnosis and living with ovarian cancer, as well as stories from individuals diagnosed with the ...

Understanding ovarian cancer’s early warning signs has long challenged medical professionals, making risk factor awareness crucial for prevention. While sexual activity itself doesn’t directly ...

Successfully launch avutometinib plus defactinib in recurrent KRAS mutant low-grade serous ovarian cancer (LGSOC) in the U.S. and continue to advance the regulatory pathway in Japan and Europe ...

The pathway controls the production of heat shock ... NXP800 drug make great progress in clinical studies for ovarian cancer, so it is very exciting to see that it could potentially also benefit ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...